What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.54%Above 5Y avg (0.60%)
Annual Rate
CNY 0.10Paid unknown
Payout Ratio
31.9%Sustainable
Payback Period
60.2 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.70BCNY
703.95M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
21.13x
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
777.21MCNY
116.50M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
28.95%
vs Medical Devices peers
Updated Oct 21, 2026
Beta
0.3730x
vs all stocks
Updated Oct 21, 2026
52-Week Change
10.08%
vs all stocks
Updated Oct 21, 2026
Forward Annual Dividend Yield
1.54%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
4.70BCNY
703.95M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
3.16BCNY
474.06M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
21.13x
vs Medical Devices peers
Updated Oct 21, 2026
Forward P/E
32.75x
vs Medical Devices peers
Updated Oct 21, 2026
Price to Sales (TTM)
6.04x
vs Medical Devices peers
Updated Oct 21, 2026
Price to Book (MRQ)
1.62x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to Revenue
4.07x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to EBITDA
25.38x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.54×.Updated Oct 21, 2026
Gross Margin
71.96%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 57.86%.Updated Oct 21, 2026
Profit Margin
28.95%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Margin
25.98%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Assets (TTM)
1.65%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Equity (TTM)
7.49%
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
777.21MCNY
116.50M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
1.08CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-32.70%
vs Medical Devices peers
Updated Oct 21, 2026
Gross Profit (TTM)
449.71MCNY
67.41M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
217.54MCNY
32.61M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
225.01MCNY
33.73M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
207.60%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
235.23MCNY
35.26M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
228.49MCNY
34.25M · vs all stocks (USD)
Updated Oct 21, 2026
Forward Annual Dividend Rate
0.1000CNYUpdated Oct 21, 2026
Forward Annual Dividend Yield
1.54%
vs all stocks
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.1000CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
1.54%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.60%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
31.87%
vs Medical Devices peers
Updated Oct 21, 2026
Minority Interest (Equity)
30.04MCNYFY2025 · Dec 31, 2025
Revenue
963.06MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
445.50MCNYFY2025 · Dec 31, 2025
Gross Profit
517.56MCNYFY2025 · Dec 31, 2025
Operating Income
112.08MCNY
16.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
145.48MCNYFY2025 · Dec 31, 2025
Income Tax Expense
13.86MCNYFY2025 · Dec 31, 2025
Net Income
131.62MCNYFY2025 · Dec 31, 2025
EBIT
152.95MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
207.84MCNYFY2025 · Dec 31, 2025
Research & Development
51.41MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
157.39MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.95MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.08MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
7.47MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1881CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1881CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
717.10MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
717.10MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
131.62MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.27MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
148.26MCNYFY2025 · Dec 31, 2025
Free Cash Flow
86.64MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
235.28MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
131.62MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
23.24MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
13.87MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-20.47MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-61.62MCNYFY2025 · Dec 31, 2025
Net Acquisitions
155.33MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-37.02MCNYFY2025 · Dec 31, 2025
Sale of Investments
112.80MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-437.01MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-267.53MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
225.67MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-218.88MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-4.60MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-5.95MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-3.77MCNYFY2025 · Dec 31, 2025
Shares Outstanding
717.01MSharesUpdated Oct 21, 2026
Float Shares
548.33MSharesUpdated Oct 21, 2026
% Held by Insiders
28.79%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
0.00%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
1.62BCNY
242.20M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
2.25CNYUpdated Oct 21, 2026
Total Debt (MRQ)
51.53MCNY
7.72M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0175x
vs Medical Devices peers
Updated Oct 21, 2026
Current Ratio (MRQ)
13.43x
vs Medical Devices peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
4.05CNYUpdated Oct 21, 2026
Total Assets
3.07BCNY
460.79M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.04BCNYFY2025 · Dec 31, 2025
Total Liabilities
181.03MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.03BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
17.13MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
163.91MCNYFY2025 · Dec 31, 2025
Cash
285.37MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.05MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
288.42MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.23BCNYFY2025 · Dec 31, 2025
Accounts Receivable
77.66MCNYFY2025 · Dec 31, 2025
Inventory
307.73MCNYFY2025 · Dec 31, 2025
Accounts Payable
21.78MCNYFY2025 · Dec 31, 2025
Short-term Debt
44.84MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.90MCNYFY2025 · Dec 31, 2025
Long-term Debt
9.38MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
717.01MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.26BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.89BCNY
433.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.10CNYUpdated Oct 21, 2026
52-Week High
7.33CNYUpdated Oct 21, 2026
52-Week Change
10.08%
vs all stocks
Updated Oct 21, 2026
Beta
0.3730x
vs all stocks
Updated Oct 21, 2026
50-Day MA
6.19CNYUpdated Oct 21, 2026
200-Day MA
6.25CNYUpdated Oct 21, 2026
Avg 10-Day Volume
11.74MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
7.31MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.3100CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 13.43×, higher than 95% of its Medical Devices peers (median 3.82×)Significant
Current ratio: 13.43Industry median: 3.82Industry P95: 11.74Peers compared: 105